References
- Whitesides GM : The origins and the future of microfluidics.Nature442(7101) , 368–373 (2006).
- Dittrich PS , ManzA: Lab-on-a-chip: microfluidics in drug discovery.Nat. Rev. Drug Discov.5(3) , 210–218 (2006).
- El-Ali J , SorgerPK, JensenKF: Cells on chips.Nature442(7101) , 403–411 (2006).
- Komen J , WolbersF, FrankeHR, AnderssonH, VermesI, van den Berg A: Viability analysis and apoptosis induction of breast cancer cells in a microfluidic device: effect of cytostatic drugs. Biomed. Microdevices10(5) , 727–737 (2008).
- Maheswaran S , SequistLV, NagrathS et al.: Detection of mutations in EGFR in circulating lung-cancer cells.N. Engl. J. Med.359(4) , 366–377 (2008).
References
- Kane MD , SpringerJA, SpragueJE: Drug safety assurance through clinical genotyping: near-term considerations for a system-wide implementation of personalized medicine.Personalized Medicine5(4) , 387–397 (2008).
- Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature447 , 661–678 (2007).
- Roden D , PulleyJ, BasfordM et al.: Development of a large-scale de-identified DNA biobank to enable personalized medicine.Clin. Pharmacol. Ther. (2008) (Epub ahead of Print).
- Pulley JM , BraceMM, BernardGR, MasysDR: Attitudes and perceptions of patients towards methods of establishing a DNA biobank.Cell Tissue Bank.9 , 55–65 (2008).